RFI – Bioscavenger Medical Countermeasures
The U.S. Department of Defense is seeking information from organizations on their capability to support advanced development of human butyrylcholinesterase ...
The U.S. Department of Defense is seeking information from organizations on their capability to support advanced development of human butyrylcholinesterase ...
The Defense Threat Reduction Agency Joint Science and Technology Office (DTRA/JSTO) is seeking potential producers of human Butyrylcholinesterase (HuBChE) for ...
The DoD Medical Countermeasure Systems-Chemical Defense Pharmaceuticals (MCS-CDP) Joint Product Management Office has a requirement to develop and deliver FDA ...
The Defense Threat Reduction Agency (DTRA) has awarded a $1.9 million grant to researchers at the University of Nebraska Medical ...
PharmAthene announced last week that it has fulfilled its obligations under a fixed price, indefinite delivery, indefinite quantity (IDIQ) contract, ...
PharmAthene, Inc. this week announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) is seeking quotations for the development and production of genetically ...
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) is seeking services to develop rapidly absorbed and persistent bioscavengers. ...
Nerve agent sarin bound to bioscavenger enzyme. Courtesy of UT. Researchers at the University of Tennessee at Knoxville (UT) are ...
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) hosted its 19th Biennial Medical Defense Bioscience Review, “Advances in ...
PharmAthene, Inc. announced this week that it has terminated its definitive merger agreement with Theraclone Sciences, Inc. with consent from ...
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) is seeking synthetic chemistry contract support for the synthesis of ...
The Department of Defense this week announced a notable contract award related to the field of chemical, biological, radiological and ...
The Defense Threat Reduction Agency (DTRA) Chemical and Biological Defense Program (CBDP) has extended the proposal receipt deadline for the ...
The Defense Threat Reduction Agency (DTRA) Chemical and Biological Defense Program (CBDP) is soliciting innovative research proposals to develop nanostructured ...
The Defense Threat Reduction Agency this week announced a new Broad Agency Announcement (BAA) amendment to solicit research proposals for ...
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) hosted its 18th Biennial Medical Defense Bioscience Review last month ...
The deadline is quickly approaching on an Army sponsored Request for Proposals (RFP) to develop nerve agent prophylactics. The overall ...